Patent · US Active

Combination formulation of two antiviral compounds

US11707479B2 · kind B2 · utility

0Cited by

200References

34Claims

0Family size

Assignee

Gilead Sciences, Inc. · US

Inventors

Eric Gorman · Hayward, US
Erik Mogalian · Redwood City, US
Reza Oliyai · Burlingame, US
Dimitrios Stefanidis · Saratoga, US
Lauren Wiser · San Francisco, US
Vahid Zia · Palo Alto, US

Key dates

Filing date	Aug 11, 2021
Grant date	Jul 25, 2023
Priority date	—
Expiry date	Aug 11, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are pharmaceutical compositions comprising Compound I, having the formula: and an effective amount of sofosbuvir wherein the sofosbuvir is substantially crystalline. Also disclosed are methods of use for the pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.